506 related articles for article (PubMed ID: 27760307)
1. Molecular genetics of osteosarcoma.
Rickel K; Fang F; Tao J
Bone; 2017 Sep; 102():69-79. PubMed ID: 27760307
[TBL] [Abstract][Full Text] [Related]
2. Genomics and the Immune Landscape of Osteosarcoma.
Wu CC; Livingston JA
Adv Exp Med Biol; 2020; 1258():21-36. PubMed ID: 32767232
[TBL] [Abstract][Full Text] [Related]
3. Advances in computational approaches for prioritizing driver mutations and significantly mutated genes in cancer genomes.
Cheng F; Zhao J; Zhao Z
Brief Bioinform; 2016 Jul; 17(4):642-56. PubMed ID: 26307061
[TBL] [Abstract][Full Text] [Related]
4. Exome-Scale Discovery of Hotspot Mutation Regions in Human Cancer Using 3D Protein Structure.
Tokheim C; Bhattacharya R; Niknafs N; Gygax DM; Kim R; Ryan M; Masica DL; Karchin R
Cancer Res; 2016 Jul; 76(13):3719-31. PubMed ID: 27197156
[TBL] [Abstract][Full Text] [Related]
5. Experimental Study of Somatic Variants of Osteosarcoma by Whole-Exome Sequencing.
Hou J; Liu G; Zhang P; Wang B; Yan Q; Wu P; Wang C; Yao W
Med Sci Monit; 2020 Mar; 26():e920826. PubMed ID: 32193367
[TBL] [Abstract][Full Text] [Related]
6.
Sakthikumar S; Elvers I; Kim J; Arendt ML; Thomas R; Turner-Maier J; Swofford R; Johnson J; Schumacher SE; Alföldi J; Axelsson E; Couto CG; Kisseberth WC; Pettersson ME; Getz G; Meadows JRS; Modiano JF; Breen M; Kierczak M; Forsberg-Nilsson K; Marinescu VD; Lindblad-Toh K
Cancer Res; 2018 Jul; 78(13):3421-3431. PubMed ID: 29724721
[TBL] [Abstract][Full Text] [Related]
7. Genome-Informed Targeted Therapy for Osteosarcoma.
Sayles LC; Breese MR; Koehne AL; Leung SG; Lee AG; Liu HY; Spillinger A; Shah AT; Tanasa B; Straessler K; Hazard FK; Spunt SL; Marina N; Kim GE; Cho SJ; Avedian RS; Mohler DG; Kim MO; DuBois SG; Hawkins DS; Sweet-Cordero EA
Cancer Discov; 2019 Jan; 9(1):46-63. PubMed ID: 30266815
[TBL] [Abstract][Full Text] [Related]
8. [Lung cancer molecular testing, what role for Next Generation Sequencing and circulating tumor DNA].
Pécuchet N; Legras A; Laurent-Puig P; Blons H
Ann Pathol; 2016 Jan; 36(1):80-93. PubMed ID: 26803564
[TBL] [Abstract][Full Text] [Related]
9. Genomic Complexity of Osteosarcoma and Its Implication for Preclinical and Clinical Targeted Therapies.
Schott C; Shah AT; Sweet-Cordero EA
Adv Exp Med Biol; 2020; 1258():1-19. PubMed ID: 32767231
[TBL] [Abstract][Full Text] [Related]
10. Personalized comprehensive molecular profiling of high risk osteosarcoma: Implications and limitations for precision medicine.
Subbiah V; Wagner MJ; McGuire MF; Sarwari NM; Devarajan E; Lewis VO; Westin S; Kato S; Brown RE; Anderson P
Oncotarget; 2015 Dec; 6(38):40642-54. PubMed ID: 26510912
[TBL] [Abstract][Full Text] [Related]
11. Whole-exome sequencing reveals recurrent somatic mutation networks in cancer.
Liu X; Wang J; Chen L
Cancer Lett; 2013 Nov; 340(2):270-6. PubMed ID: 23153794
[TBL] [Abstract][Full Text] [Related]
12. Next generation sequencing reveals genetic landscape of hepatocellular carcinomas.
Li S; Mao M
Cancer Lett; 2013 Nov; 340(2):247-53. PubMed ID: 23063663
[TBL] [Abstract][Full Text] [Related]
13. Genome-wide analyses on high-grade osteosarcoma: making sense of a genomically most unstable tumor.
Kuijjer ML; Hogendoorn PC; Cleton-Jansen AM
Int J Cancer; 2013 Dec; 133(11):2512-21. PubMed ID: 23436697
[TBL] [Abstract][Full Text] [Related]
14. Subclonal Somatic Copy-Number Alterations Emerge and Dominate in Recurrent Osteosarcoma.
Kinnaman MD; Zaccaria S; Makohon-Moore A; Arnold B; Levine MF; Gundem G; Arango Ossa JE; Glodzik D; Rodríguez-Sánchez MI; Bouvier N; Li S; Stockfisch E; Dunigan M; Cobbs C; Bhanot UK; You D; Mullen K; Melchor JP; Ortiz MV; O'Donohue TJ; Slotkin EK; Wexler LH; Dela Cruz FS; Hameed MR; Glade Bender JL; Tap WD; Meyers PA; Papaemmanuil E; Kung AL; Iacobuzio-Donahue CA
Cancer Res; 2023 Nov; 83(22):3796-3812. PubMed ID: 37812025
[TBL] [Abstract][Full Text] [Related]
15. Complementary genomic approaches highlight the PI3K/mTOR pathway as a common vulnerability in osteosarcoma.
Perry JA; Kiezun A; Tonzi P; Van Allen EM; Carter SL; Baca SC; Cowley GS; Bhatt AS; Rheinbay E; Pedamallu CS; Helman E; Taylor-Weiner A; McKenna A; DeLuca DS; Lawrence MS; Ambrogio L; Sougnez C; Sivachenko A; Walensky LD; Wagle N; Mora J; de Torres C; Lavarino C; Dos Santos Aguiar S; Yunes JA; Brandalise SR; Mercado-Celis GE; Melendez-Zajgla J; Cárdenas-Cardós R; Velasco-Hidalgo L; Roberts CW; Garraway LA; Rodriguez-Galindo C; Gabriel SB; Lander ES; Golub TR; Orkin SH; Getz G; Janeway KA
Proc Natl Acad Sci U S A; 2014 Dec; 111(51):E5564-73. PubMed ID: 25512523
[TBL] [Abstract][Full Text] [Related]
16. Translational cell biology of highly malignant osteosarcoma.
Roessner A; Lohmann C; Jechorek D
Pathol Int; 2021 May; 71(5):291-303. PubMed ID: 33631032
[TBL] [Abstract][Full Text] [Related]
17. The mini-driver model of polygenic cancer evolution.
Castro-Giner F; Ratcliffe P; Tomlinson I
Nat Rev Cancer; 2015 Nov; 15(11):680-5. PubMed ID: 26456849
[TBL] [Abstract][Full Text] [Related]
18. Exome and deep sequencing of clinically aggressive neuroblastoma reveal somatic mutations that affect key pathways involved in cancer progression.
Lasorsa VA; Formicola D; Pignataro P; Cimmino F; Calabrese FM; Mora J; Esposito MR; Pantile M; Zanon C; De Mariano M; Longo L; Hogarty MD; de Torres C; Tonini GP; Iolascon A; Capasso M
Oncotarget; 2016 Apr; 7(16):21840-52. PubMed ID: 27009842
[TBL] [Abstract][Full Text] [Related]
19. Personalized genomic analyses for cancer mutation discovery and interpretation.
Jones S; Anagnostou V; Lytle K; Parpart-Li S; Nesselbush M; Riley DR; Shukla M; Chesnick B; Kadan M; Papp E; Galens KG; Murphy D; Zhang T; Kann L; Sausen M; Angiuoli SV; Diaz LA; Velculescu VE
Sci Transl Med; 2015 Apr; 7(283):283ra53. PubMed ID: 25877891
[TBL] [Abstract][Full Text] [Related]
20. Reviewing the somatic genetics of melanoma: from current to future analytical approaches.
Dutton-Regester K; Hayward NK
Pigment Cell Melanoma Res; 2012 Mar; 25(2):144-54. PubMed ID: 22248438
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
